Targeting CDK9 for treatment of colorectal cancerMuhammed H. Rahaman(University of South Australia), Shudong Wang(The University of Adelaide)Molecular OncologyAugust 9, 201910.1002/1878-0261.12559Cited by 57SaveCiteExport RISWatch citationsRelated PapersTargeting Mnks for Cancer Therapy|Oncotarget|2012|138Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73|Oncotarget|2014|53Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation|Molecules|2023|8